Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Beh çet's Disease: National Multicenter Study of 177 Cases

ConclusionAlthough both IFX and ADA are efficacious in refractory BD ‐related uveitis, ADA appears to be associated with better outcomes than IFX after 1 year of follow‐up.

Source: Arthritis and Rheumatology - October 20, 2019 Category: Rheumatology Authors: Bel én Atienza‐Mateo, José Luis Martín‐Varillas, Vanesa Calvo‐Río, Rosalía Demetrio‐Pablo, Emma Beltrán, Juan Sánchez‐Bursón, Marina Mesquida, Alfredo Adan, María Victoria Hernández, Marisa Hernández‐Garfella, Elia Valls� Tags: Original Article Source Type: research